A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis

NCT00658047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: CH-1504
DRUG: Methotrexate (MTX)

Sponsor

Chelsea Therapeutics